UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 371

Sortiert nach

Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers

Breast care (Basel, Switzerland), 2021-04, Vol.16 (2), p.144-148

Singer, Christian F.

2021

Volltextzugriff (PDF)

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1128-1135

2015

Volltextzugriff (PDF)

Genetic Testing in Breast Cancer: New Standards of Care

Breast care (Basel, Switzerland), 2021-06, Vol.16 (3), p.193-195

Singer, Christian F.

2021

Volltextzugriff (PDF)

Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer

PloS one, 2015-04, Vol.10 (4), p.e0125317-e0125317

2015

Volltextzugriff (PDF)

Radiotherapy-Induced Fatigue in Breast Cancer Patients

Breast care (Basel, Switzerland), 2021-06, Vol.16 (3), p.236-242

2021

Volltextzugriff (PDF)

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Breast (Edinburgh), 2021-12, Vol.60, p.98-110

2021

Volltextzugriff (PDF)

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria

BMC cancer, 2022-10, Vol.22 (1), p.1-1099, Article 1099

2022

Volltextzugriff (PDF)

Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study

BMC cancer, 2024-07, Vol.24 (1), p.1-11, Article 856

2024

Volltextzugriff (PDF)

Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro

PloS one, 2017-09, Vol.12 (9), p.e0185566-e0185566

2017

Volltextzugriff (PDF)

7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer

Magnetic resonance imaging, 2019-06, Vol.59, p.77-87

2019

Volltextzugriff (PDF)

Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer

BMC cancer, 2023-03, Vol.23 (1), p.281-281, Article 281

2023

Volltextzugriff (PDF)

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool

PloS one, 2018-07, Vol.13 (7), p.e0200559-e0200559

2018

Volltextzugriff (PDF)

Decision theory for precision therapy of breast cancer

Scientific reports, 2021-02, Vol.11 (1), p.4233-4233, Article 4233

2021

Volltextzugriff (PDF)

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study

Breast cancer research and treatment, 2016-01, Vol.155 (2), p.365-373

2016

Volltextzugriff (PDF)

The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy

Breast (Edinburgh), 2017-06, Vol.33, p.153-158

2017

Volltextzugriff (PDF)

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-300, Article 300

2023

Volltextzugriff (PDF)

Receptor Discordance of Metastatic Breast Cancer Depending on the Molecular Subtype

Breast care (Basel, Switzerland), 2020-12, Vol.15 (6), p.648-654

2020

Volltextzugriff (PDF)

Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients

Breast care (Basel, Switzerland), 2017-12, Vol.12 (6), p.401-408

2017

Volltextzugriff (PDF)

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer

BMC cancer, 2019-07, Vol.19 (1), p.695-695, Article 695

2019

Volltextzugriff (PDF)

Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer

Molecular cancer research, 2011-12, Vol.9 (12), p.1767-1779

2011

Volltextzugriff (PDF)

Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy

Journal of personalized medicine, 2023-01, Vol.13 (1), p.119

2023

Volltextzugriff (PDF)

BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

PloS one, 2012-09, Vol.7 (9), p.e44753-e44753

2012

Volltextzugriff (PDF)

1 – 25 von 371

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(349)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(35)
Breast Cancer Research And Treatment
(29)
Cancer Research
(25)
Clinical Cancer Research
(23)
Plos One
(12)
Breast Care
(11)
Bmc Cancer
(9)
Breast Cancer Research : Bcr
(7)
Gynecologic Oncology
(7)
Wiener Klinische Wochenschrift
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density

Genetic Testing in Breast Cancer: New Standards of Care

Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer

Radiotherapy-Induced Fatigue in Breast Cancer Patients

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria

Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study

Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro

7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer

Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool

Decision theory for precision therapy of breast cancer

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study

The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Receptor Discordance of Metastatic Breast Cancer Depending on the Molecular Subtype

Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer

Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy

Tamoxifen and Anastrozole As a Sequencing Strategy: A Randomized Controlled Trial in Postmenopausal Patients With Endocrine-Responsive Early Breast Cancer From the Austrian Breast and Colorectal Cancer Study Group

BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

Suchergebnisse filtern